Covidien Mesh Lawsuit Set For Trial in Feb. 2026, Over Defective Hernia Implant

“Bellwether” trial will be the first Covidien mesh case to go before a jury involving claims that the collagen layer of a Covidien Symbotex hernia implant failed, resulting in painful injuries and complications.

The U.S. District Judge presiding over all federal Covidien mesh lawsuits has scheduled a bellwether trial to begin in February 2026, which will be closely watched to see how juries may respond in more than 1,700 similar claims involving injuries allegedly caused by design defects linked to popular hernia implants used in recent years.

Medtronic and its Covidien subsidiary face product liability lawsuits brought by individuals throughout the U.S., each involving similar claims that plaintiffs suffered painful and debilitating complications due to various different defective hernia implants, including the Covidien Parietex, Covidien Symbotex and other mesh products.

The company is just one of several manufacturers of polyethylene hernia mesh products who have recently faced similar litigation, resulting in tens of thousands of lawsuits filed over Bard hernia implants, Ethicon’s Physiomesh and Atrium’s C-Qur mesh products, each of which ended in global settlement agreements in recent years. However, Covidien continues to fight the mesh lawsuits and has indicated it intends to defend the cases at trial.

Given common questions of fact and law presented in lawsuits brought throughout the federal court system, a Covidien mesh lawsuit MDL (multidistrict litigation) was established in 2022, centralizing the cases before U.S. District Judge Patti B. Saris in the District of Massachusetts, for coordinated discovery and pretrial proceedings.

First Covidien Mesh Lawsuit Trial

At Judge Saris’s behest, the parties have been preparing a small group of Covidien mesh “bellwether” lawsuits for early trial dates, which were selected since they are representative of the litigation as a whole.  

While the outcome of early mesh trials will not be binding on other plaintiffs, they will be closely watched to help the parties see how jurors may respond to a typical claim. Judge Saris hopes that the results of these trials will lead the parties to a Covidien mesh settlement agreement, which will avoid the need for hundreds of individual cases to be set for trial.

Following a series of Covidien hernia mesh settlement talks held late last month and early this month, Judge Saris issued a court order (PDF) on April 8, announcing that the first bellwether lawsuit will go before a jury on February 17, 2026.

The first bellwether trial will involve a lawsuit filed by Larry and Tammy Patterson, of Alabama, in January 2022. The complaint (PDF) indicates that Larry Patterson was implanted with a Covidien Symbotex mesh in July 2017, and the hernia implant failed, resulting in the need for additional surgery three years later after the mesh caused an obstruction in his small bowel.

According to the lawsuit, the adhesions were due to his body’s premature resorption of a collagen layer, which was supposed to prevent those very types of complications. The claim indicates Patterson suffered an intense and chronic inflammatory response to the mesh, resulting in severe pain, adhesions, and the need to undergo a small bowel resection, and intervention surgery to remove the failed hernia implant.

Judge Saris’s order set a series of key dates leading up to a deadline for the parties to submit a pretrial memorandum on January 27, 2026, and a pretrial conference scheduled for February 4, 2026, two weeks before the trial begins.

After the bellwether trials have been completed, if no Covidien mesh lawsuit settlement has been reached, then it is likely that Judge Saris would remand the cases back to their originating court for individual trial dates.  There are also hundreds of additional lawsuits against Covidien pending in the Massachusetts state court system.